by Ricky Solorzano, CEO, Allevi
In an era where bioprinting continues to hold promise sometimes its hard to understand why and how are they useful. What key applications will allow me to take my research to the next level and stay on the cutting edge. Come and listen to the key ways bioprinting is being most commonly used by researchers around the world.
What drives you?
Seeing how many users are doing new Science on Allevi platforms is awesome. The vision and the belief that 3d bioprinting can trully personalize medicine is also a huge factors.
Why should the delegate attend your presentation?
People should come to see how 3D printing is playing a role in tissue engineering to enhance how we study biology.
What emerging technologies/trends do you see as having the greatest potential in the short and long run?
3D bioprinting is a playing a big role to ask novel question in materials science, biology, and tissue engineering. In the future we should be excited to see how it plays an influence in how we test novel drugs.
What kind of impact do you expect them to have?
By being able to create the body outside the body in a more accurate way we should be able to drugs to market in a quicker more personalized fashion. This is going to lower the cost of healthcare and improve its precision.
What are the barriers that might stand in the way?
The barriers that stand in the way today are novel designs, bioink development, and further validation. We need biologist, disease model specialist, and pharmacologist using 3D bioprinting to increase its impact in the market.
Allevi is excited to be providing the world a foundation in 3D Bioprinting to allow new science in tissue and organ engineering
About Ricky Solorzano
Ricky Solorzano as the CEO of Allevi guides the vision, strategy, and day to day operation. He has been obsessed with tissue engineering for 8 years, created the first desktop 3D bioprinter out of his dorm room, and has been a Forbes 30 under 30, Inc 30 under 30, and Business Insider 100: The Creators #65.
About Allevi, Inc
Allevi is building tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers all around the world to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life.
Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinter to be the most versatile, powerful and easy-to-use bioprinter on the market. Since our humble beginnings, we have grown to serve hundreds of labs in all corners of the world and have become leaders in the biofabrication revolution.
We are constantly inspired by our community of users who are performing world-class research on our platform. When your work has life changing implications for people all over the world, it’s an amazing responsibility. That ingenuity. That importance. That’s Allevi. We believe everyone has the potential to change the course of medicine.